World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   18067 records for 4326 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of Registration
RecruitingNoNCT03189576
Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases
14/06/2017
RecruitingYesNCT03186989
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's Disease
06/06/2017
RecruitingYesNCT03171311
The OCTOBER Trial - Nordic-Baltic-British Study on Optical Coherence Tomography Optimized Bifurcation Event Reduction
28/05/2017
Not recruitingYesACTRN12617000748314
Dark chocolate flavanols and cognition, FlaSeCo-study
22/05/2017
Not recruitingYesNCT03172715
Prosthesis Versus Osteosynthesis in Proximal Tibia Fractures
22/05/2017
Not recruitingYesNCT03162653
Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome
18/05/2017
RecruitingYesNCT03167814
Prevention of Chyle-leak After Major Pancreatic Surgery
15/05/2017
Not recruitingYesNCT03155997
A Study to Compare Treatment After Surgery of Abemaciclib (LY2835219) Combined With Standard Endocrine Therapy Versus Endocrine Therapy Alone in Participants With Breast Cancer
15/05/2017
AuthorisedYesEUCTR2016-004822-41-FI
Assess safety and efficacy of vilaprisan in subjects with uterine fibroids
15/05/2017
AuthorisedYesEUCTR2016-002778-11-FI
A Randomized, Double-blind, Phase 2 Trial to investigate how safe and how efficacious Lenvatinib is at two different starting doses (18 mg vs. 14 mg QD) when it is given in Combination with Everolimus (5 mg once a day ) in patients with Renal cancer that have already had one VEGF-Targeted Treatment 11/05/2017
     
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.3 - Version history